ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
From - Laboratory Industry Report
The business of enforcing federal health care fraud laws isn't as robust as it used to be. While revenues have…
From - Laboratory Industry Report
Several companies market an array of preventive tests directly to consumers. Are these companies and tests legit? What does…
By Sean McSweeney bio
Does your orthopedic billing company charge a percentage of collections for their coding and billing…
From - Laboratory Industry Report
The strategic deal making pot continues to boil, despite the relative inactivity of the established market leaders like Quest, LabCorp and Abbott. Here's a look at…
From - Laboratory Industry Report
Patients are making increasing use of physician rating and review sites to comment on their medical experiences the way diners do with restaurants. And as with…
From - Laboratory Industry Report
Over the past several years, the FDA has issued Emergency Use Authorization (EUA) for over a dozen different tests for…
From - Laboratory Industry Report
Here's a summary of the key product launches from late May through the third week of…
From - Laboratory Industry Report
The diagnostics industry got off to a so-so start with PAMA reimbursement cuts, a weak flu season relative to…